Antimetabolites are a class of chemotherapy drugs that masquerade as the building blocks of DNA and RNA (purines and pyrimidines). Once the cancer cell incorporates these "false" molecules into its metabolic pathways, the synthesis of new genetic material is halted, or the resulting DNA is non-functional. These drugs are S-phase specific, meaning they are most effective during the active...

Antimetabolites are a class of chemotherapy drugs that masquerade as the building blocks of DNA and RNA (purines and pyrimidines). Once the cancer cell incorporates these "false" molecules into its metabolic pathways, the synthesis of new genetic material is halted, or the resulting DNA is non-functional. These drugs are S-phase specific, meaning they are most effective during the active...

Oligonucleotide Synthesis Market was valued at US$ 6.60 Bn in 2023 and is expected to reach 17.43 Bn by 2030, at a CAGR of 14.87% during the forecast period. Market Overview As of the most recent Oligonucleotide Synthesis Market update, the global economic landscape reflects a dynamic interplay of various factors. Major financial markets continue to navigate the aftermath of the...

Polaris Market Research has announced the latest report, namely DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Type (Oligonucleotide Synthesis and Gene Synthesis), By Application, By End-User, and By Region – Market Forecast, 2025–2034, that examines the overall market condition both now and in the future. It provides comprehensive and accurate research...

Polaris Market Research has announced the latest report, namely DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Type (Oligonucleotide Synthesis and Gene Synthesis), By Application, By End-User, and By Region – Market Forecast, 2025–2034, that examines the overall market condition both now and in the future. It provides comprehensive and accurate research...

Polaris Market Research has published a new report titled Enzymatic DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Services (Oligonucleotide Synthesis and Gene Synthesis), By Technology, By Application, By End Use, and By Region – Market Forecast, 2025–2034 that delivers up-to-date analysis with analyses of the current and future effects of the...

Polaris Market Research has published a new report titled Enzymatic DNA Synthesis Market Size, Share, Trends, Industry Analysis Report By Services (Oligonucleotide Synthesis and Gene Synthesis), By Technology, By Application, By End Use, and By Region – Market Forecast, 2025–2034 that delivers up-to-date analysis with analyses of the current and future effects of the...

While services and diagnostics define much of today's demand, the oligonucleotide synthesis market is also being shaped by chemistry choices, manufacturing investment, and the growth of nucleic acid medicines. Polaris Market Research reports that the market was valued at USD 3.55 billion in 2025 and is projected to grow from USD 4.07 billion in 2026 to USD 12.49 billion by 2034, at a CAGR of...

Polaris Market Research today announced findings from its latest report, projecting the global Oligonucleotide Synthesis market to grow from USD 3.55 billion in 2025 to USD 12.49 billion by 2034, at a CAGR of 15.01% from 2026 to 2034. The report profiles 14 leading companies across five market segmentation categories. Analyst Commentary on Oligonucleotide Synthesis Market Growth “Market...

Valued at USD 4.26 billion in 2025, the DNA synthesis market is projected to reach USD 4.96 billion in 2026 and USD 17.24 billion by 2034, growing at a CAGR of 16.85% during the forecast period 2026–2034. Major players include Twist Bioscience Corporation, DNA Script SAS, Molecular Assemblies, Inc., Integrated DNA Technologies, Inc., GenScript Biotech Corporation, Thermo Fisher...